MedTrace Logo

BActeriophages To Treat Liver Disease Eliminating Harmful Bacteria (BATTLE)

NCT05618418 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-11-16

No results posted yet for this study

Summary

Alcoholic hepatitis is a disease with a high mortality rate with few treatment options improving survival. Recently certain bacterial strains has been correlated to survival in patients with alcoholic hepatitis.

In the BATTLE-trial the investigators will investigate if certain bacteria are correlated to decreased chance of survival in patients with alcoholic hepatitis.

Conditions

  • Alcoholic Hepatitis

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Copenhagen University Hospital at Herlev

    collaborator OTHER

  • Copenhagen University Hospital, Hvidovre

    lead OTHER

Principal Investigators

  • frederik cold, MD, PHD · Copenhagen University Hospital, Hvidovre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2025-01-01
Completion
2026-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618418 on ClinicalTrials.gov